Following the green light from the Medicines and Healthcare products Regulatory Agency (MHRA), the NHS in England will be the first health system in the world to roll out the seven-minute injection to hundreds of patients each year.
Currently, patients receive the life-extending immunotherapy atezolizumab (Tencentriq®) in hospital directly into their veins via a drug transfusion.
It usually takes around 30 minutes to administer intravenous atezolizumab, but for some patients this can be up to an hour when it can be difficult to access a vein…
